Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
166.41 USD
1.06%
Market Closed
Updated:
Apr 20, 2024
Abbvie Inc
Long-Term Investments
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Long-Term Investments Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Long-Term Investments
$304m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
10%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Long-Term Investments
$1.2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Long-Term Investments
$2.6B
|
CAGR 3-Years
398%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Long-Term Investments
$5.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
30%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Long-Term Investments?
Long-Term Investments
304m
USD
304m
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Long-Term Investments amounts to 304m USD.
What is Abbvie Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
10%
10%
Over the last year, the Long-Term Investments growth was 26%. The average annual Long-Term Investments growth rates for Abbvie Inc have been 1% over the past three years , -27% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
